EX-99.(H)(5) 2 jhct-html4839_ex99h5.htm EXPENSE LIMITATION LETTER AGREEMENT DATED DECEMBER 9, 2021 BETWEEN THE REGISTRANT AND JOHN HANCOCK INVESTMENT MANAGEMENT LLC (FORMERLY KNOWN AS JOHN HANCOCK ADVISERS, LLC)

Exhibit (h)(5)

 

John Hancock Investment Management LLC  
200 Berkeley Street
Boston, MA  02116

December 9, 2021

To the Trustees of

John Hancock Collateral Trust

200 Berkeley Street

Boston, MA 02116

Re: Expense Limitation Letter Agreement

 

With reference to the Advisory Agreement entered into by and between John Hancock Investment Management LLC (the “Adviser”) and John Hancock Collateral Trust (the “Trust”), on behalf of its series John Hancock Collateral Trust (the “Fund”), we hereby notify you as follows:

 

1. The Adviser agrees to contractually waive its advisory fee for the Fund as set forth in the appendix attached hereto.

 

2. We understand and intend that the Trust will rely on this undertaking in accruing the Fund’s expenses for purposes of calculating its net and gross asset value per share, and for other purposes permitted under the Investment Company Act of 1940, as amended, and we expressly permit the Trust so to rely.

 

 

    Very truly yours,
     
    JOHN HANCOCK INVESTMENT MANAGEMENT LLC
      By: /s/ Jeffrey H. Long
        Jeffrey H. Long
        Chief Financial Officer

 

 

Agreed and Accepted

on behalf of John Hancock Collateral Trust

   
By: /s/ Charles A. Rizzo      
  Charles A. Rizzo      
  Chief Financial Officer      
  

 

APPENDIX A

Fund Level Contractual Investment Management Waiver

For purposes of this Appendix:

 

The Adviser contractually agrees to waive its advisory fee by 0.45% of the Fund’s average daily net assets. This fee waiver expires April 30, 2023, unless renewed by mutual agreement of the Fund and the Adviser based upon a determination that this is appropriate under the circumstances at that time.*

 

*At the December 7-9, 2021 meeting of the Board of Trustees of the Trust, the Adviser notified the Board of, and the Board approved, the extension of the expiration date (to April 30, 2023) of the fee waiver arrangement, effective upon the current expiration date of April 30, 2022.

A-1